Pharmaceutical Serialization Mandates Drive Print Redesign
Brand-protection programs increasingly reformulate premium anti-counterfeit specifications toward genuine printed chipless chemistry rather than conventional chip-based design, since ultra-low-cost item-level serialization accuracy genuinely requires the print-yield integration older tag formats cannot provide across nearly every premium pharmaceutical and brand-protection qualification program tracked in this report. Roughly 24% of new packaging lines now feature documented printed chipless integration, up meaningfully from a decade ago when standard chip-based formats alone remained the unquestioned default across nearly every packaging category. This shift raises average contract value while locking makers into design-in relationships smaller regional operators cannot easily contest.
Market Impact: Broadened across 22% more categories








